biomodal, a leading omics-based life sciences technology and analytics company, has announced the launch of its Certified Service Provider (CSP) Program, a new global initiative aimed at expanding access to its duet multiomics sequencing technologies. The program brings together a…
The IMA Group (IMA), a leading national provider of medical and psychological evaluations and clinical research services, has announced the acquisition of Chicago Research Center (CRC), an independent, Chicago-based clinical research site with a strong reputation in central nervous system…
Calira, formerly known as Clustermarket, has announced a major rebrand and the appointment of Edmund Wilson, co-founder and former CEO of Titian Software (now Cenevo), as a non-executive director and investor. The move underscores Calira’s strategy to strengthen its position…
Kernal Biologics, Inc., a venture-backed TechBio company transforming the treatment landscape through mRNA-based in vivo cell programming, announced it has been awarded up to $48 million in funding from the Advanced Research Projects Agency for Health (ARPA-H). The award comes…
Hesperos, Inc., a global leader in developing Human-on-a-Chip® (HoaC) technology for improving preclinical testing across pharmaceuticals, food, cosmetics, and chemicals, has announced a groundbreaking advancement in neuroscience research. In collaboration with Bayer Consumer Health, the company has unveiled the first…
BioSkryb Genomics, a leader in single-cell and ultra–low-input multiomic technologies, has announced the launch of its ResolveSEQ LongRead Early Access Program, in collaboration with Eremid® Genomic Services, a high-complexity genomics contract research organization (CRO) and Certified Service Provider (CSP) for…
Membrion, a pioneering ceramic desalination membrane innovator, has successfully completed a $20 million Series B1 funding round, marking a significant milestone in its mission to revolutionize industrial water management. The round was anchored by leading climate-tech and materials investors, including…
Seek Labs, a biotechnology company at the forefront of AI-driven drug discovery and programmable therapeutics, has announced major progress in the development of what could become the world’s first pan-orthopoxvirus therapeutic. This next-generation treatment aims to provide broad protection against…
Alpenglow Biosciences, a pioneer in AI-powered 3D pathology, has announced a strategic multi-year partnership with Virdx, a biophysics AI company specializing in MRI-based cancer detection. The collaboration aims to accelerate the development of next-generation diagnostic tools, combining the strengths of…
Near Space Labs, a leading innovator in stratospheric robotics and Earth observation technology, announced that Tom Chi, founding member of Google X and former head of Project Loon, has joined the company as a strategic investor and board observer. Chi’s…